SPDR SER TR - S&P PHARMAC (XPH)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / S&P PHARMAC
Shares, excl. options Q1 2024
2.42 M
Holdings value Q1 2024
$105 M
Value change Q1 2024
-$2.1 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
69
Number of buys Q1 2024
30
Number of sells Q1 2024
-23
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
78464A722
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 2.42 M $105 M -$2.1 M $43.13 69
2023 Q4 2.47 M $103 M +$12.8 M $41.62 66
2023 Q3 2.15 M $85.4 M -$14.3 M $39.75 60
2023 Q2 2.84 M $116 M +$32 M $40.99 54
2023 Q1 2.05 M $84.3 M -$23.6 M $41.01 56
2022 Q4 2.63 M $108 M -$6.51 M $40.95 67
2022 Q3 2.75 M $110 M +$9.43 M $40.16 59
2022 Q2 2.5 M $104 M +$18.3 M $42.00 63
2022 Q1 2.04 M $92.2 M -$12 M $45.27 63
2021 Q4 2.3 M $106 M +$14.6 M $46.15 72
2021 Q3 2.03 M $96.1 M -$2.21 M $47.43 74
2021 Q2 2.06 M $107 M -$23.4 M $51.76 76
2021 Q1 2.52 M $127 M -$10.7 M $50.35 78
2020 Q4 2.71 M $141 M +$16.3 M $52.06 75
2020 Q3 2.42 M $105 M -$12.4 M $43.48 69
2020 Q2 2.71 M $117 M -$13.2 M $42.98 68
2020 Q1 3.03 M $109 M -$50.1 M $36.07 62
2019 Q4 4.04 M $185 M -$75.6 M $45.67 71
2019 Q3 5.73 M $204 M +$64.2 M $35.59 55
2019 Q2 3.88 M $154 M -$22.7 M $39.83 57
2019 Q1 4.44 M $184 M +$33.2 M $41.58 77
2018 Q4 3.65 M $134 M -$21.6 M $36.62 66
2018 Q3 4.01 M $195 M +$33 M $48.56 78
2018 Q2 3.37 M $145 M -$32.9 M $43.01 63
2018 Q1 4.35 M $182 M +$53.7 M $41.87 69
2017 Q4 2.98 M $130 M -$50.8 M $43.50 80
2017 Q3 4.05 M $172 M +$1.76 M $42.55 74
2017 Q2 3.99 M $172 M -$4.98 M $43.03 75
2017 Q1 4.12 M $172 M +$14.3 M $41.83 74
2016 Q4 3.8 M $148 M -$696 K $39.09 74
2016 Q3 3.78 M $167 M +$3.1 M $44.19 66
2016 Q2 3.71 M $155 M -$114 M $41.79 56
2016 Q1 6.45 M $259 M +$46.3 M $40.24 68
2015 Q4 5.29 M $271 M -$17.3 M $51.20 74
2015 Q3 5.56 M $261 M +$115 M $46.92 76
2015 Q2 2.8 M $349 M +$3.39 M $124.70 81
2015 Q1 2.78 M $343 M -$7.15 M $123.52 76
2014 Q4 2.86 M $308 M +$18.3 M $107.96 76
2014 Q3 2.68 M $284 M -$53.9 M $106.01 72
2014 Q2 3.2 M $332 M +$17.7 M $103.80 67
2014 Q1 3.05 M $286 M +$10.2 M $93.61 70